Table 2.
Unadjusted Associations of Retention Measures with Sociodemographic and Clinical Variables
| Established Care | Met Retention Criterion in All Outpatient Years | No Loss to Follow-up > 12 months | Met all Three Criteria | |
|---|---|---|---|---|
| N | 22,984 | 17,988 | 17,988 | 22,984 |
| Overall | 78.3% | 42.6% | 65.1% | 20.4% |
| Gender*¶ | ||||
| Female | 79.9 | 42.2 | 67.6 | 21.4 |
| Male | 77.7 | 42.7 | 64.1 | 20.1 |
| Race/Ethnicity*ঠ | ||||
| White | 76.8 | 43.7 | 60.0 | 18.9 |
| Black | 79.9 | 40.1 | 67.6 | 20.6 |
| Hispanic | 78.1 | 46.6 | 66.6 | 22.8 |
| Other | 75.8 | 45.6 | 59.4 | 19.7 |
| Missing | 59.3 | 42.1 | 56.3 | 11.1 |
| Risk Group*¶‡ | ||||
| MSM | 80.2 | 43.3 | 64.0 | 21.2 |
| HET | 81.0 | 40.8 | 68.8 | 21.7 |
| IDU | 71.7 | 45.8 | 62.4 | 19.1 |
| HET+IDU | 84.0 | 39.9 | 64.2 | 20.1 |
| MSM+IDU | 80.8 | 39.8 | 57.8 | 16.6 |
| Missing | 56.3 | 50.6 | 54.1 | 13.3 |
| Age at Enrollmentঠ | ||||
| 18-29 | 77.0 | 36.8 | 63.0 | 16.5 |
| 30-39 | 77.8 | 39.4 | 61.3 | 17.1 |
| 40-49 | 78.8 | 45.0 | 66.6 | 22.4 |
| 50+ | 79.5 | 50.5 | 72.0 | 27.9 |
| Initial Insurance*ঠ | ||||
| Private | 79.9 | 44.3 | 67.6 | 22.5 |
| Medicaid | 77.3 | 46.0 | 67.1 | 22.3 |
| Medicare/Dual | 76.6 | 52.7 | 69.0 | 27.1 |
| None/Ryan White | 77.9 | 39.8 | 65.4 | 18.9 |
| Missing | 81.2 | 34.6 | 55.3 | 14.3 |
| Initial CD4 Cell Count*ঠ | ||||
| <50 | 77.6 | 45.8 | 70.4 | 24.0 |
| 51-200 | 78.9 | 44.4 | 66.1 | 21.6 |
| 201-350 | 77.0 | 44.4 | 65.7 | 21.0 |
| 351-500 | 77.2 | 42.5 | 64.5 | 20.0 |
| 501+ | 76.5 | 42.6 | 62.9 | 18.9 |
| Missing | 96.0 | 24.3 | 59.1 | 13.1 |
| Year of First Visit*ঠ | ||||
| 2001 | 77.9 | 34.0 | 50.2 | 10.2 |
| 2002 | 83.9 | 33.7 | 54.1 | 13.1 |
| 2003 | 84.2 | 36.6 | 55.0 | 15.0 |
| 2004 | 78.7 | 39.6 | 56.1 | 14.5 |
| 2005 | 75.3 | 41.8 | 61.9 | 17.0 |
| 2006 | 77.4 | 46.1 | 71.5 | 24.1 |
| 2007 | 75.5 | 50.3 | 80.3 | 27.9 |
| 2008 | 73.0 | 60.7 | 95.1 | 40.7 |
| First HIV-1 RNA*ঠ | ||||
| Not suppressed | 77.2 | 43.0 | 65.5 | 20.4 |
| Suppressed | 78.1 | 46.7 | 66.5 | 22.9 |
| Missing | 86.0 | 30.2 | 59.1 | 14.4 |
Note: MSM – Men who have sex with men; IDU – injection drug use; HET – heterosexual transmission.
*
p< 0.01 for association with establishing care.
‡
p<0.01 for association with continuous retention.
¶
p<0.01 for association with loss to follow-up.
†
p<0.01 for association with meeting all three criteria.